Anaptysbio (ANAB) Operating Margin Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) Operating Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | 309,598.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,598.00 |
| Dec 31, 2025 | 60,866.00 |
| Sep 30, 2025 | 236,121.00 |
| Jun 30, 2025 | 216,855.00 |
| Mar 31, 2025 | 317,393.00 |
| Dec 31, 2024 | 304,312.00 |
| Sep 30, 2024 | -11,790.00 |
| Jun 30, 2024 | -36,486.00 |
| Mar 31, 2024 | -40,423.00 |
| Dec 31, 2023 | -52,348.00 |
| Mar 31, 2023 | -302,645.00 |
| Dec 31, 2022 | 22,247.00 |
| Jun 30, 2022 | -175,296.00 |
| Sep 30, 2021 | 30,392.00 |
| Dec 31, 2020 | 29,394.00 |
| Dec 31, 2019 | -42,453.00 |
| Jun 30, 2019 | -59,222.00 |